{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:32:50Z","timestamp":1772263970385,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T00:00:00Z","timestamp":1383177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10096-013-1999-1","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T00:34:47Z","timestamp":1383179687000},"page":"639-649","source":"Crossref","is-referenced-by-count":19,"title":["Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment"],"prefix":"10.1007","volume":"33","author":[{"given":"M. S.","family":"Duthie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Guderian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vallur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lima dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Vieira de Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ribeiro de Jesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Todt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. G.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,31]]},"reference":[{"key":"1999_CR1","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M; WHO Leishmaniasis Control Team (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7:e35671","journal-title":"PLoS One"},{"key":"1999_CR2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/infdis\/173.6.1515","volume":"173","author":"O Bacellar","year":"1996","unstructured":"Bacellar O, Brodskyn C, Guerreiro J, Barral-Netto M, Costa CH, Coffman RL, Johnson WD, Carvalho EM (1996) Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis. J Infect Dis 173:1515\u20131518","journal-title":"J Infect Dis"},{"key":"1999_CR3","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1006\/cyto.2000.0694","volume":"12","author":"O Bacellar","year":"2000","unstructured":"Bacellar O, D\u2019Oliveira A Jr, Jer\u00f4nimo S, Carvalho EM (2000) IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis. Cytokine 12:1228\u20131231","journal-title":"Cytokine"},{"key":"1999_CR4","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.152.12.5949","volume":"152","author":"EM Carvalho","year":"1994","unstructured":"Carvalho EM, Bacellar O, Brownell C, Regis T, Coffman RL, Reed SG (1994) Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 152:5949\u20135956","journal-title":"J Immunol"},{"key":"1999_CR5","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1172\/JCI112209","volume":"76","author":"EM Carvalho","year":"1985","unstructured":"Carvalho EM, Badar\u00f3 R, Reed SG, Jones TC, Johnson WD Jr (1985) Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 76:2066\u20132069","journal-title":"J Clin Invest"},{"key":"1999_CR6","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/168.4.986","volume":"168","author":"P Cenini","year":"1993","unstructured":"Cenini P, Berhe N, Hailu A, McGinnes K, Frommel D (1993) Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. J Infect Dis 168:986\u2013993","journal-title":"J Infect Dis"},{"key":"1999_CR7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1006\/cyto.1995.0088","volume":"7","author":"E Cillari","year":"1995","unstructured":"Cillari E, Vitale G, Arcoleo F, D\u2019Agostino P, Mocciaro C, Gambino G, Malta R, Stassi G, Giordano C, Milano S, Mansueto S (1995) In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis. Cytokine 7:740\u2013745","journal-title":"Cytokine"},{"key":"1999_CR8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1590\/S0074-02762012000600005","volume":"107","author":"AS Costa","year":"2012","unstructured":"Costa AS, Costa GC, Aquino DM, Mendon\u00e7a VR, Barral A, Barral-Netto M, Caldas Ade J (2012) Cytokines and visceral leishmaniasis: a comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis. Mem Inst Oswaldo Cruz 107:735\u2013739","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1999_CR9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2334-13-331","volume":"13","author":"FA Oliveira de","year":"2013","unstructured":"de Oliveira FA, Vanessa Oliveira Silva C, Damascena NP, Passos RO, Duthie MS, Guderian JA, Bhatia A, de Moura TR, Reed SG, de Almeida RP, de Jesus AR (2013) High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis. BMC Infect Dis 13:331","journal-title":"BMC Infect Dis"},{"key":"1999_CR10","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1371\/journal.pntd.0000419","volume":"3","author":"T Duffy","year":"2009","unstructured":"Duffy T, Bisio M, Altcheh J, Burgos JM, Diez M, Levin MJ, Favaloro RR, Freilij H, Schijman AG (2009) Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients. PLoS Negl Trop Dis 3:e419","journal-title":"PLoS Negl Trop Dis"},{"key":"1999_CR11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijpara.2010.11.005","volume":"41","author":"AI Elshafie","year":"2011","unstructured":"Elshafie AI, Hlin E, H\u00e5kansson LD, Elghazali G, Safi SH, R\u00f6nnelid J, Venge P (2011) Activity and turnover of eosinophil and neutrophil granulocytes are altered in visceral leishmaniasis. Int J Parasitol 41:463\u2013469","journal-title":"Int J Parasitol"},{"key":"1999_CR12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2249.1998.00468.x","volume":"111","author":"S Gasim","year":"1998","unstructured":"Gasim S, Elhassan AM, Khalil EA, Ismail A, Kadaru AM, Kharazmi A, Theander TG (1998) High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin Exp Immunol 111:64\u201369","journal-title":"Clin Exp Immunol"},{"key":"1999_CR13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","volume":"92","author":"HW Ghalib","year":"1993","unstructured":"Ghalib HW, Piuvezam MR, Skeiky YA, Siddig M, Hashim FA, el-Hassan AM, Russo DM, Reed SG (1993) Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 92:324\u2013329","journal-title":"J Clin Invest"},{"key":"1999_CR14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1128\/CVI.00473-10","volume":"18","author":"K Gidwani","year":"2011","unstructured":"Gidwani K, Picado A, Ostyn B, Singh SP, Kumar R, Khanal B, Lejon V, Chappuis F, Boelaert M, Sundar S (2011) Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India. Clin Vaccine Immunol 18:346\u2013348","journal-title":"Clin Vaccine Immunol"},{"key":"1999_CR15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0035-9203(90)90141-Z","volume":"84","author":"A Hailu","year":"1990","unstructured":"Hailu A (1990) Pre- and post-treatment antibody levels in visceral leishmaniasis. Trans R Soc Trop Med Hyg 84:673\u2013675","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1999_CR16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4269\/ajtmh.2004.71.561","volume":"71","author":"A Hailu","year":"2004","unstructured":"Hailu A, van der Poll T, Berhe N, Kager PA (2004) Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis. Am J Trop Med Hyg 71:561\u2013567","journal-title":"Am J Trop Med Hyg"},{"key":"1999_CR17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/infdis\/167.2.411","volume":"167","author":"BJ Holaday","year":"1993","unstructured":"Holaday BJ, Pompeu MM, Evans T, Braga DN, Texeira MJ, Sousa Ade Q, Sadick MD, Vasconcelos AW, Abrams JS, Pearson RD, Locksley RM (1993) Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi. J Infect Dis 167:411\u2013417","journal-title":"J Infect Dis"},{"key":"1999_CR18","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1172\/JCI116878","volume":"92","author":"BJ Holaday","year":"1993","unstructured":"Holaday BJ, Pompeu MM, Jer\u00f4nimo S, Texeira MJ, Sousa Ade A, Vasconcelos AW, Pearson RD, Abrams JS, Locksley RM (1993) Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest 92:2626\u20132632","journal-title":"J Clin Invest"},{"key":"1999_CR19","first-page":"7","volume":"66","author":"H Louis","year":"2003","unstructured":"Louis H, Le Moine O, Goldman M, Devi\u00e8re J (2003) Modulation of liver injury by interleukin-10. Acta Gastroenterol Belg 66:7\u201314","journal-title":"Acta Gastroenterol Belg"},{"key":"1999_CR20","doi-asserted-by":"crossref","first-page":"e1542","DOI":"10.1371\/journal.pntd.0001542","volume":"6","author":"TS Machado de Assis","year":"2012","unstructured":"Machado de Assis TS, Rabello A, Werneck GL (2012) Predictive models for the diagnostic of human visceral leishmaniasis in Brazil. PLoS Negl Trop Dis 6:e1542","journal-title":"PLoS Negl Trop Dis"},{"key":"1999_CR21","doi-asserted-by":"crossref","first-page":"e1484","DOI":"10.1371\/journal.pntd.0001484","volume":"6","author":"Z Maia","year":"2012","unstructured":"Maia Z, L\u00edrio M, Mistro S, Mendes CMC, Mehta SR, Badar\u00f3 R (2012) Comparative study of rK39 Leishmania antigen for serodiagnosis of visceral leishmaniasis: systematic review with meta-analysis. PLoS Negl Trop Dis 6:e1484","journal-title":"PLoS Negl Trop Dis"},{"key":"1999_CR22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.actatropica.2011.05.009","volume":"119","author":"AC Maretti-Mira","year":"2011","unstructured":"Maretti-Mira AC, de Pinho Rodrigues KM, de Oliveira-Neto MP, Pirmez C, Craft N (2011) MMP-9 activity is induced by Leishmania braziliensis infection and correlates with mucosal leishmaniasis. Acta Trop 119:160\u2013164","journal-title":"Acta Trop"},{"key":"1999_CR23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/IAI.01388-07","volume":"76","author":"E McFarlane","year":"2008","unstructured":"McFarlane E, Perez C, Charmoy M, Allenbach C, Carter KC, Alexander J, Tacchini-Cottier F (2008) Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani. Infect Immun 76:532\u2013541","journal-title":"Infect Immun"},{"key":"1999_CR24","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1586\/eri.10.78","volume":"8","author":"S Mondal","year":"2010","unstructured":"Mondal S, Bhattacharya P, Ali N (2010) Current diagnosis and treatment of visceral leishmaniasis. Expert Rev Anti Infect Ther 8:919\u2013944","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1999_CR25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","volume":"118","author":"LF Oliveira","year":"2011","unstructured":"Oliveira LF, Schubach AO, Martins MM, Passos SL, Oliveira RV, Marzochi MC, Andrade CA (2011) Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta Trop 118:87\u201396","journal-title":"Acta Trop"},{"key":"1999_CR26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-3156.2008.02195.x","volume":"14","author":"P Olliaro","year":"2009","unstructured":"Olliaro P, Sundar S (2009) Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India. Trop Med Int Health 14:88\u201392","journal-title":"Trop Med Int Health"},{"key":"1999_CR27","doi-asserted-by":"crossref","first-page":"e1545","DOI":"10.1371\/journal.pntd.0001545","volume":"6","author":"P Olliaro","year":"2012","unstructured":"Olliaro P, Vaillant MT, Sundar S, Balasegaram M (2012) More efficient ways of assessing treatments for neglected tropical diseases are required: innovative study designs, new endpoints, and markers of effects. PLoS Negl Trop Dis 6:e1545","journal-title":"PLoS Negl Trop Dis"},{"key":"1999_CR28","doi-asserted-by":"crossref","unstructured":"Pattabhi S, Whittle J, Mohamath R, El-Safi S, Moulton GG, Guderian JA, Colombara D, Abdoon AO, Mukhtar MM, Mondal D, Esfandiari J, Kumar S, Chun P, Reed SG, Bhatia A (2010) Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis. PLoS Negl Trop Dis 4. pii: e822","DOI":"10.1371\/journal.pntd.0000822"},{"key":"1999_CR29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.trstmh.2007.11.004","volume":"102","author":"MJ Pedras","year":"2008","unstructured":"Pedras MJ, de Gouv\u00eaa Viana L, de Oliveira EJ, Rabello A (2008) Comparative evaluation of direct agglutination test, rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg 102:172\u2013178","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1999_CR30","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/nrmicro1765","volume":"5","author":"RG Ridley","year":"2007","unstructured":"Ridley RG (2007) Evaluating diagnostics: VL. Nat Rev Microbiol 5:S1","journal-title":"Nat Rev Microbiol"},{"key":"1999_CR31","doi-asserted-by":"crossref","unstructured":"Sana G, Lombard C, Vosters O, Jazouli N, Andre F, Stephenne X, Smets F, Najimi M, Sokal EM (2013) Adult human hepatocytes promote CD4+ T cell hyporesponsiveness via interleukin-10 producing allogeneic dendritic cells. Cell Transplant","DOI":"10.3727\/096368913X666421"},{"key":"1999_CR32","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/JCM.41.4.1529-1535.2003","volume":"41","author":"A Schulz","year":"2003","unstructured":"Schulz A, Mellenthin K, Sch\u00f6nian G, Fleischer B, Drosten C (2003) Detection, differentiation, and quantitation of pathogenic leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay. J Clin Microbiol 41:1529\u20131535","journal-title":"J Clin Microbiol"},{"key":"1999_CR33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/CVI.00143-12","volume":"19","author":"OP Singh","year":"2012","unstructured":"Singh OP, Gidwani K, Kumar R, Nyl\u00e9n S, Jones SL, Boelaert M, Sacks D, Sundar S (2012) Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. Clin Vaccine Immunol 19:961\u2013966","journal-title":"Clin Vaccine Immunol"},{"key":"1999_CR34","doi-asserted-by":"crossref","first-page":"e19304","DOI":"10.1371\/journal.pone.0019304","volume":"6","author":"P Srivastava","year":"2011","unstructured":"Srivastava P, Mehrotra S, Tiwary P, Chakravarty J, Sundar S (2011) Diagnosis of Indian visceral leishmaniasis by nucleic acid detection using PCR. PLoS One 6:e19304","journal-title":"PLoS One"},{"key":"1999_CR35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","volume":"14","author":"S Sundar","year":"2013","unstructured":"Sundar S, Chakravarty J (2013) Leishmaniasis: an update of current pharmacotherapy. Expert Opin Pharmacother 14:53\u201363","journal-title":"Expert Opin Pharmacother"},{"key":"1999_CR36","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","volume":"362","author":"S Sundar","year":"2010","unstructured":"Sundar S, Chakravarty J, Agarwal D, Rai M, Murray HW (2010) Single-dose liposomal amphotericin B for visceral leishmaniasis in India. N Engl J Med 362:504\u2013512","journal-title":"N Engl J Med"},{"key":"1999_CR37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0035-9203(00)90277-3","volume":"94","author":"S Sundar","year":"2000","unstructured":"Sundar S, Gupta LB, Rastogi V, Agrawal G, Murray HW (2000) Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis. Trans R Soc Trop Med Hyg 94:200\u2013204","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1999_CR38","first-page":"394","volume":"83","author":"S Sundar","year":"2005","unstructured":"Sundar S, Murray HW (2005) Availability of miltefosine for the treatment of kala-azar in India. Bull World Health Organ 83:394\u2013395","journal-title":"Bull World Health Organ"},{"key":"1999_CR39","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/591972","volume":"47","author":"S Sundar","year":"2008","unstructured":"Sundar S, Rai M, Chakravarty J, Agarwal D, Agrawal N, Vaillant M, Olliaro P, Murray HW (2008) New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine. Clin Infect Dis 47:1000\u20131006","journal-title":"Clin Infect Dis"},{"key":"1999_CR40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0090-1229(95)90144-2","volume":"77","author":"T Poll van der","year":"1995","unstructured":"van der Poll T, Zijlstra EE, Mevissen M (1995) Interleukin 6 during active visceral leishmaniasis and after treatment. Clin Immunol Immunopathol 77:111\u2013114","journal-title":"Clin Immunol Immunopathol"},{"key":"1999_CR41","doi-asserted-by":"crossref","first-page":"e10107","DOI":"10.1371\/journal.pone.0010107","volume":"5","author":"S Verma","year":"2010","unstructured":"Verma S, Kumar R, Katara GK, Singh LC, Negi NS, Ramesh V, Salotra P (2010) Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis. PLoS One 5:e10107","journal-title":"PLoS One"},{"key":"1999_CR42","unstructured":"World Health Organization (WHO) (2010) Leishmaniasis: burden of disease, surveillance & control, epidemics, access to medicines, information resources. Available online at: http:\/\/www.who.int\/leishmaniasis\/en\/"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-013-1999-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-013-1999-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-013-1999-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T21:30:42Z","timestamp":1688592642000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-013-1999-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,31]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1999"],"URL":"https:\/\/doi.org\/10.1007\/s10096-013-1999-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,31]]}}}